The Circular Prescription: How Pharma and Hospitals Are Transforming Waste into Iconic Design

The Circular Prescription: How Pharma and Hospitals Are Transforming Waste into Iconic Design

In the mission-critical environments of the pharmaceutical industry and healthcare, every product decision is scrutinized. Yet, amidst the sterile necessity of single-use materials, a profound sustainability challenge emerges: medical plastic waste.

For organizations committed to Net Zero goals, solving this complex waste stream is no longer optional—it’s a strategic imperative. We are proud to share the story of the R.U.M. Chair in Pharma Blue—a piece of furniture that is not just a beautiful design statement but a tangible commitment to the circular economy, forged directly from the industry’s own waste.


 

The Pharma Waste Challenge: From Single-Use to Strategic Asset

 

The plastic used in medical devices, particularly injection pens, is high-quality but often chemically complex. After single use, this material frequently bypasses conventional recycling and ends up in incineration or landfill, contradicting the core values of planetary health and resource efficiency.

Wehlers and its partners have successfully intervened in this process, redefining the value of this waste:

The Pharma Blue edition of the R.U.M. (Re-Used Materials) Chair is crafted from a single, pure source of post-consumer plastic: recycled injection pens (Pharmalit).

This is the power of a FULL circular economy in action: taking necessary medical plastic that would otherwise be landfilled and re-engineering it into a durable, design-forward asset.

 

Quantifying the Circular Impact

 

The shift to Pharma Blue is a strategic choice with clear, quantifiable environmental benefits for procurement and reporting:

  • 142 Injection Pens Per Chair: Each chair directly removes waste from the system, giving new life to approximately 142 used insulin pens collected through specialized networks in Scandinavia.

  • Massive Carbon Reduction: The single-material, recycled design ensures the R.U.M. Chair in Pharma Blue has a carbon footprint of approximately 15.2 kg CO₂e, representing a reduction of over 60% compared to conventional benchmark chairs.

  • Designed for Infinite Recycling: The chair is made from only two pure materials (recycled plastic seat/back and recycled steel base) which are easily separable. This engineering choice guarantees that the chair can be taken back by Wehlers and recycled 100% into new, high-quality R.U.M. products at the end of its life, eliminating future landfill liability.


 

Case Studies: Industry Leaders Set the Benchmark

 

For organizations leading the way in ESG (Environmental, Social, and Governance) and circular procurement, aligning interior design with core sustainability values is crucial. We are honored to partner with industry giants and major healthcare institutions who understand this necessity.

 

Novo Nordisk: Closing the Loop in Corporate Settings

 

Global pharmaceutical leader Novo Nordisk has shown remarkable vision by incorporating the Pharma Blue R.U.M. Chair into their offices as part of their ambitious Circular4Zero program.

By choosing a chair made from their industry's own waste, Novo Nordisk transforms office seating into a tangible, daily reminder of their corporate responsibility to close the loop on plastic use. This move is a powerful internal and external statement, turning a waste challenge into a design win.

 

Odense University Hospital (OUH): Sustainable Healthcare Infrastructure

 

Hospitals are complex, high-traffic environments where furniture must meet strict standards for durability and hygiene. Odense University Hospital (OUH) recognized that sustainability must extend from medical procedures to facility design.

By choosing the R.U.M. Chair, OUH is demonstrating that it is possible to furnish high-stakes healthcare spaces with products that meet functional demands while contributing directly to ocean and planetary health by removing and reusing specialized plastics.


 

The Call to Action for Circular Procurement

 

For Procurement, Facilities, and Sustainability leaders in the healthcare and pharma sectors, the Pharma Blue R.U.M. Chair offers a compelling competitive advantage:

  1. Simplify ESG Reporting: Easily integrate the chair's specific low-carbon footprint and closed-loop material sourcing into your annual sustainability reports.

  2. Activate Employee Engagement: Provide a concrete, visible symbol of the company's values that resonates with staff committed to environmental stewardship.

  3. Future-Proof Your Assets: Invest in furniture guaranteed to remain in the circular economy via the Wehlers take-back system.

The circular prescription is simple: Reduce, Reuse, and Redesign your waste into lasting value.


Ready to transform your industry’s waste into iconic, sustainable design?


Leave a comment

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.